STAIDSON
DEAD

Serial Number

86238081

Owner

Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Attorney

Alex Patel

First Use Date

Sep 19, 2014

Filing Date

Apr 1, 2014

Add to watchlist:

No watchlists yet
View on USPTO

STAIDSON Trademark

Serial Number: 86238081 • Registration: 4689978

STAIDSON is a trademark filed by Staidson (Beijing) Biopharmaceuticals Co., Ltd. on April 1, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Staidson (Beijing) Biopharmaceuticals Co., Ltd. (6 trademarks)

Beijing Econ. & Tech. Development Zone
Beijing , CN

Entity Type: 99

Trademark Details

Filing Date

April 1, 2014

Registration Date

February 17, 2015

First Use Anywhere

September 19, 2014

First Use in Commerce

September 19, 2014

Published for Opposition

August 19, 2014

Cancellation Date

September 24, 2021

Goods & Services

Medicines for human purposes, for the treatment of injury of optic nerve; Medicines for human purposes, for the treatment of functional constipation and for treatment of intestinal conditions; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; Medicines, namely, acetylsalicylic acid tablets for treatment of antithrombosis and for the treatment of unstable angina; Medicines for human purposes, for the treatment of pruritus and alopecia; Medicines for human purposes, for weight loss; Medicines for human purposes, for treatment of hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Medicines for human purposes, for the treatment of infectious disease; Pharmaceutical preparations for the treatment of autoimmune disorders; Medicines for treating constipation

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 24, 2021 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 17, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 17, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 16, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 15, 2015 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 7, 2015 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 6, 2015 AITU
USE AMENDMENT FILED
Nov 21, 2014 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 21, 2014 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 14, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 14, 2014 XAEC
ASSIGNED TO LIE
Jul 11, 2014 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2014 CNEA
ASSIGNED TO EXAMINER
Jul 8, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2014 NWOS
NEW APPLICATION ENTERED
Apr 4, 2014 NWAP